Skip to main content
×
×
Home

What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment

  • Bengt Jönsson (a1) and Paul E. Bebbington (a2)
Abstract

The purpose of this study was twofold: to measure the overall direct costs of depression for 1990 in the UK, and to develop a model to illustrate issues in the evaluation of the relative cost-effectiveness of the pharmacological treatment of depression. We compared a tricyclic antidepressant, imipramine, with paroxetine, a newer antidepressant. For assessing the cost of illness, we used a top-down approach. We calculated direct but not indirect costs. Cost-effectiveness was evaluated by developing a simulation model based on the theory of clinical decision analysis to compare the costs and outcome of each treatment. From this we estimated the expected cost per patient and the cost per successfully treated patient. The total cost to the nation of depressive illness was estimated to be £222 million. The expected costs per patient were found to be similar for paroxetine and imipramine (£430 v. £424). The costs per successfully treated patient were found to be lower for paroxetine (£824) than for imipramine (£1024). The results were stable when a sensitivity analysis was applied to the variables employed in the model. The most sensitive variable was the cost of treatment failure. Our model thus reveals that medication that appears expensive in terms of cost per day may not be so when patient compliance and the total costs of treatment are taken into account.

Copyright
Corresponding author
Correspondence
References
Hide All
Bebbington, P. E. (1987) Marital status and depression: a study of English national admission statistics. Acta Psychiatrica Scandinavica, 75, 640650.
Bridges, K. & Goldberg, D. (1988) Somatic presentations of psychiatric illness in primary care setting. Journal of Psychosomatic Research, 32, 137144.
Drummond, M. F., Stodderd, G. L. & Torrance, G. W. (1982) Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications.
Dunbar, G. C., Cohn, J. B., Fabre, L. F., et al (1991) A comparison of paroxetine, imipramine and placebo in depressed outpatients. British Journal of Psychiatry, 159, 394398.
Fadden, G. B., Bebbington, P. E. & Kuipers, L. (1987a) The burden of care: the impact of functional psychiatric illness on the patient's family. British Journal of Psychiatry, 150, 285292.
Fadden, G. B., Kuipers, L. & Bebbington, P. E. (1987b) Caring and its burdens: a study of the relatives of depressed patients. British Journal of Psychiatry, 151, 660667.
Freeung, P., Rao, B. M., Paykel, E. S., et al (1985) Unrecognized depression in general practice. British Medical Journal, 290, 18801883.
Hatziandreu, E., Turner, R., Revicki, D., et al (1992) Cost-utility analysis of maintenance treatment for recurrent depression in the UK. Paper presented at the Second Workshop on Costs and Assessment in Psychiatry: the Costs of Affective Disorders, Venice, 26–28 October, 1992.
Hodgson, T. A. (1989) Cost of illness studies: no aid to decision making? Health Policy, 11, 5760.
Hodgson, T. A. & Meiners, M. R. (1982) Cost-of-Illness methodology: A guide to current practices and procedures. Millbank Memorial Fund Quarterly/Health and Society, 60, 429491.
Hurry, J., Bebbington, P. E. & Tennant, C. (1987) Psychiatric symptoms and social disablement as determinants of illness behaviour. Australian and New Zealand Journal of Psychiatry, 21, 6874.
Jönsson, B. (1983) Review of the macro-economic evaluation of cimetidine. In Economic Evaluation of Health Technologies (eds Culyer, A. J. & Horisberger, B.), pp. 241261. Berlin: Springer.
Jönsson, B. & Carlsson, P. (1991) The effects of cimetidine on the cost of ulcer disease in Sweden. Social Science and Medicine, 33, 275282.
Jönsson, B. & Bebbington, P. (1993) Economic studies of the treatment of depressive illness. In Health Economics of Depression (eds Jönsson, B. & Rosenbaum, J.), pp. 3548. Chichester: Wiley.
Kind, P. & Sorensen, J. (1993) The costs of depression. International Clinical Psychopharmacology, 7, 191195.
Klerman, G. L. (1988) The current age of youthful melancholia: evidence for increase in depression among adolescents and young adults. British Journal of Psychiatry, 152, 414.
Kramer, M., Brown, H., Skinner, M., et al (1987) Changing living arrangements in the population and their potential effect on the prevalence of mental disorder: Findings of the East Baltimore mental health survey. In Psychiatric Epidemiology: Progress and Prospects (ed. Cooper, B.), pp. 326. London: Croom Helm.
Lönnqvist, J., Sintonen, H., Appleberg, B., et al (1992) Moclobemide and fluoxetine in depression: impact on quality of life and costs. Paper presented at the Second Workshop on Costs and Assessment in Psychiatry: the Costs of Affective Disorders, Venice, 26–28 October, 1992.
McCombs, J. S., Nichol, M. B., Stimmel, G. L., et al (1990) The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population. Journal of Clinical Psychiatry, 51, 6069.
Mehrez, A. & Gafni, A. (1989) Quality-adjusted life years, utility theory and health-years equivalents. Medical Decision Making, 9, 142149.
Paykel, E. S., Weissman, M. M. & Prusoff, B. S. (1978) Social maladjustment and severity of depression. Comprehensive Psychiatry, 19, 121128.
Prescription Pricing Authority, Department of Health (1988) Prescription Cost Analysis System. London: HMSO.
Rice, D. P. (1992) Conceptual and estimation issues related to cost of illness studies. Paper presented at the Second Workshop on Costs and Assessment in Psychiatry: the Costs of Affective Disorders, Venice, 26–28 October, 1992.
Robins, L. N. & Regier, D. A. (1991) Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press.
Sartorius, N. (1975) Epidemiology of depression. WHO Chronicle, 29, 423427.
Schwab, J. J., Bell, R. A., Warheit, G. J., et al (1979) Social Order and Mental Health: The Florida Health Study. New York: Brunner/Mazel.
Shiell, A., Gerard, K. & Donaldson, C. (1987) Cost of illness studies: an aid to decision-making? Health Policy, 8, 317323.
Sono, F., Freemantle, N., Shelton, T. A., et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683687.
Stoudemire, A., Frank, R., Hedemark, N., et al (1986) The economic burden of depression. General Hospital Psychiatry, 8, 387394.
Weinstein, M. C. & Fineberg, H. V. (1980) Clinical Decision Analysis. Philadelphia: W.B. Saunders.
Weissman, M., Prussoff, B., Thompson, W., et al (1978) Social adjustment by self report in a community sample and in psychiatric out-patients. Journal of Nervous and Mental Disease, 166, 317376.
West, R. (1992) Depression. London: Office of Health Economics.
World Health Organization (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Geneva: WHO.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 8 *
Loading metrics...

Abstract views

Total abstract views: 100 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 26th May 2018. This data will be updated every 24 hours.

What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment

  • Bengt Jönsson (a1) and Paul E. Bebbington (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *